Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

63 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A randomized factorial trial comparing 4 treatment regimens in treatment-naive HIV-infected persons with AIDS and/or a CD4 cell count <200 cells/μL in South Africa.
Phidisa II Writing Team for Project Phidisa; Ratsela A, Polis M, Dhlomo S, Emery S, Grandits G, Khabo P, Khanyile T, Komati S, Neaton JD, Naidoo LC, Magongoa D, Qolohle D. Phidisa II Writing Team for Project Phidisa, et al. J Infect Dis. 2010 Nov 15;202(10):1529-37. doi: 10.1086/656718. Epub 2010 Oct 13. J Infect Dis. 2010. PMID: 20942650 Free PMC article. Clinical Trial.
Genotypic resistance at viral rebound among patients who received lopinavir/ritonavir-based or efavirenz-based first antiretroviral therapy in South Africa.
Dlamini JN, Hu Z, Ledwaba J, Morris L, Maldarelli FM, Dewar RL, Highbarger HC, Somaroo H, Sangweni P, Follmann DA, Pau AK; Phidisa II Study Team. Dlamini JN, et al. Among authors: pau ak. J Acquir Immune Defic Syndr. 2011 Nov 1;58(3):304-8. doi: 10.1097/QAI.0b013e3182278c29. J Acquir Immune Defic Syndr. 2011. PMID: 21694608 Free PMC article. Clinical Trial.
The pharmacist: An indispensable partner in HIV care.
Pau AK, Lane HC, Masur H. Pau AK, et al. Am J Health Syst Pharm. 2016 Apr 1;73(7):431. doi: 10.2146/ajhp160077. Am J Health Syst Pharm. 2016. PMID: 27001981 No abstract available.
Decreased Absorption of Dolutegravir and Tenofovir Disoproxil Fumarate, But Not Emtricitabine, in an HIV-Infected Patient Following Oral and Jejunostomy-Tube Administration.
Brooks KM, Garrett KL, Kuriakose SS, George JM, Balba G, Bailey B, Anderson M, Lane HC, Maldarelli F, Pau AK. Brooks KM, et al. Among authors: pau ak. Pharmacotherapy. 2017 Aug;37(8):e82-e89. doi: 10.1002/phar.1960. Epub 2017 Jul 18. Pharmacotherapy. 2017. PMID: 28556353 Free PMC article.
Early Presence of HIV-1 Subtype C in Washington, D.C.
Grossman Z, Rico SV, Cone K, Shao W, Rehm C, Jones S, Bozzi G, Dean S, Dewar R, Rehman T, Purdy J, Hadigan C, Pau AK, Maldarelli F. Grossman Z, et al. Among authors: pau ak. AIDS Res Hum Retroviruses. 2018 Aug;34(8):680-684. doi: 10.1089/AID.2018.0041. AIDS Res Hum Retroviruses. 2018. PMID: 29936863 Free PMC article.
Rapid Development of High-Level Resistance to Dolutegravir With Emergence of T97A Mutation in 2 Treatment-Experienced Individuals With Baseline Partial Sensitivity to Dolutegravir.
George JM, Kuriakose SS, Dee N, Stoll P, Lalani T, Dewar R, Khan MA, Rehman MT, Grossman Z, Maldarelli F, Pau AK. George JM, et al. Among authors: pau ak. Open Forum Infect Dis. 2018 Sep 8;5(10):ofy221. doi: 10.1093/ofid/ofy221. eCollection 2018 Oct. Open Forum Infect Dis. 2018. PMID: 30568974 Free PMC article.
63 results